{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:12:26Z","timestamp":1774689146857,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1111\/bjd.16006","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T06:58:50Z","timestamp":1506063530000},"page":"415-423","source":"Crossref","is-referenced-by-count":14,"title":["Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial"],"prefix":"10.1093","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-4082","authenticated-orcid":false,"given":"J.M.","family":"Mason","sequence":"first","affiliation":[{"name":"Warwick Medical School; University of Warwick; Coventry CV4 7AL U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-7367","authenticated-orcid":false,"given":"J.R.","family":"Chalmers","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; Nottingham NG7 2NR U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Godec","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL; Aviation House, 125 Kingsway London WC2B 6NH U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Nunn","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL; Aviation House, 125 Kingsway London WC2B 6NH U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kirtschig","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; Nottingham NG7 2NR U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wojnarowska","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Medicine; University of Oxford; Oxford OX3 7BN U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Childs","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit; Nottingham Health Science Partners; QMC; Nottingham NG7 2UH U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Whitham","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit; Nottingham Health Science Partners; QMC; Nottingham NG7 2UH U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of L\u00fcbeck; L\u00fcbeck Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Harman","sequence":"additional","affiliation":[{"name":"Dermatology Department; Leicester Royal Infirmary; University Hospitals Leicester; Leicester LE1 5WW U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Walton","sequence":"additional","affiliation":[{"name":"Castle Hill Hospital; Castle Road Cottingham Hull HU16 5JQ U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital; Greenwich, London SE18 4QH U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; Nottingham NG7 2NR U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the U.K. Dermatology Clinical Trials Network BLISTER Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"10.1111\/bjd.16006-BIB0001|bjd16006-cit-0001","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/bjd.16006-BIB0002|bjd16006-cit-0002","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the U.K.: Population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/bjd.16006-BIB0003|bjd16006-cit-0003","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: A multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16006-BIB0004|bjd16006-cit-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/bjd.16006-BIB0005|bjd16006-cit-0005","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16006-BIB0006|bjd16006-cit-0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2133.1979.tb11881.x","article-title":"The events leading to the death of patients with pemphigus and pemphigoid","volume":"101","author":"Savin","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16006-BIB0007|bjd16006-cit-0007","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists\u2019 guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16006-BIB0008|bjd16006-cit-0008","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16006-BIB0009|bjd16006-cit-0009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ced.12042","article-title":"The approach of dermatologists in the U.K. to the treatment of bullous pemphigoid: Results of a national survey","volume":"38","author":"Taghipour","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16006-BIB0010|bjd16006-cit-0010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/ced.12831","article-title":"Current practice in treatment approach for bullous pemphigoid: Comparison between national surveys from the Netherlands and U.K","volume":"41","author":"Meijer","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16006-BIB0011|bjd16006-cit-0011","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"10","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.16006-BIB0012|bjd16006-cit-0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21100","article-title":"A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg\/day) with oral prednisolone (0.5 mg\/kg\/day) for initial treatment of bullous pemphigoid: The Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial","volume":"21","author":"Chalmers","year":"2017","journal-title":"Health Technol Assess"},{"key":"10.1111\/bjd.16006-BIB0013|bjd16006-cit-0013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjd.13729","article-title":"A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg\u22121 daily) for initial treatment of bullous pemphigoid: A protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial","volume":"173","author":"Chalmers","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16006-BIB0014|bjd16006-cit-0014","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: A pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"key":"10.1111\/bjd.16006-BIB0015|bjd16006-cit-0015","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1111\/bjd.16006-BIB0016|bjd16006-cit-0016","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1745-6215-14-421","article-title":"Trial-based clinical and economic analyses: The unhelpful quest for conformity","volume":"14","author":"Whitehurst","year":"2013","journal-title":"Trials"},{"key":"10.1111\/bjd.16006-BIB0017|bjd16006-cit-0017","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","article-title":"Variations in population health status: Results from a United Kingdom national questionnaire survey","volume":"316","author":"Kind","year":"1998","journal-title":"BMJ"},{"key":"10.1111\/bjd.16006-BIB0018|bjd16006-cit-0018","unstructured":"Dolan P Gudex C Kind P Williams A A Social Tariff for EuroQol: Results From a U.K. General Population Survey https:\/\/www.york.ac.uk\/che\/pdf\/DP138.pdf"},{"key":"10.1111\/bjd.16006-BIB0019|bjd16006-cit-0019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N","article-title":"The time trade-off method: Results from a general population survey","volume":"5","author":"Dolan","year":"1996","journal-title":"Health Econ"},{"key":"10.1111\/bjd.16006-BIB0020|bjd16006-cit-0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16006-BIB0021|bjd16006-cit-0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3100","article-title":"Methods for the analysis of quality-of-life and survival data in health technology assessment","volume":"3","author":"Billingham","year":"1999","journal-title":"Health Technol Assess"},{"key":"10.1111\/bjd.16006-BIB0022|bjd16006-cit-0022","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost-effectiveness analysis: The importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"key":"10.1111\/bjd.16006-BIB0023|bjd16006-cit-0023","unstructured":"National Health Service Prescription Cost Analysis, England 2013 http:\/\/content.digital.nhs.uk\/catalogue\/PUB13887"},{"key":"10.1111\/bjd.16006-BIB0024|bjd16006-cit-0024","unstructured":"Department of Health NHS Reference Costs 2013 to 2014 www.gov.uk\/government\/publications\/nhs-reference-costs-2013-to-2014"},{"key":"10.1111\/bjd.16006-BIB0025|bjd16006-cit-0025","unstructured":"Health and Social Care Information Centre Hospital Episode Statistics, Admitted Patient Care, England - 2013-14 http:\/\/content.digital.nhs.uk\/catalogue\/PUB16719"},{"key":"10.1111\/bjd.16006-BIB0026|bjd16006-cit-0026","volume-title":"DRG Desk Reference 2016. ICD-10","year":"2015"},{"key":"10.1111\/bjd.16006-BIB0027|bjd16006-cit-0027","unstructured":"Curtis L PRSSU Unit Costs of Health and Social Care 2013 http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2013"},{"key":"10.1111\/bjd.16006-BIB0028|bjd16006-cit-0028","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/bjd.16006-BIB0029|bjd16006-cit-0029","doi-asserted-by":"crossref","first-page":"d40","DOI":"10.1136\/bmj.d40","article-title":"Strategy for intention to treat analysis in randomised trials with missing outcome data","volume":"342","author":"White","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/bjd.16006-BIB0030|bjd16006-cit-0030","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/bjd.16006-BIB0031|bjd16006-cit-0031","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1111\/bjd.16006-BIB0032|bjd16006-cit-0032","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hec.843","article-title":"Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data","volume":"13","author":"Willan","year":"2004","journal-title":"Health Econ"},{"key":"10.1111\/bjd.16006-BIB0033|bjd16006-cit-0033","unstructured":"National Institute for Health and Care Excellence Guide to the Methods of Technology Appraisal 2013 https:\/\/www.nice.org.uk\/process\/pmg9"},{"key":"10.1111\/bjd.16006-BIB0034|bjd16006-cit-0034","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(02)09832-X","article-title":"A rational framework for decision making by the National Institute for Clinical Excellence (NICE)","volume":"360","author":"Claxton","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/bjd.16006-BIB0035|bjd16006-cit-0035","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"10.1111\/bjd.16006-BIB0036|bjd16006-cit-0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19110","article-title":"Clinical trial metadata: Defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme","volume":"19","author":"Raftery","year":"2015","journal-title":"Health Technol Assess"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16006\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T05:00:43Z","timestamp":1719464443000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/2\/415\/6732189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16006","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,15]]}}}